MYL

Mylan Inc. News Headlines

$55.24
*  
1.055
1.87%
Get MYL Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYL After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Mylan: Outperformed S&P 500 Since June, And Shows No Signs Of Slowing
1/22/2015 7:52:00 AM - Seeking Alpha


SUPN In Legal Bout, NSPR Put On Notice, It''s Advantage TEVA, KTWO Gets FDA Nod
1/22/2015 12:48:00 AM - RTT News


Agree To Purchase Mylan At $35, Earn 4.5% Using Options
1/21/2015 11:53:51 AM - BNK Invest


Adamis Pharmaceuticals: A Specialty Pharma Ready For The Next Level
1/21/2015 10:54:00 AM - Seeking Alpha


Supreme Court Sides With Teva in Patent Case on Copaxone -- 2nd Update
1/20/2015 4:57:00 PM - Dow Jones Business News


Supreme Court Sides With Teva in Patent Case on Copaxone -- Update
1/20/2015 12:44:00 PM - Dow Jones Business News


Supreme Court Sides With Teva in Patent Case on Copaxone
1/20/2015 10:46:00 AM - Dow Jones Business News


Mylan Launches Generic Epivir-HBV Tablets
1/15/2015 2:50:00 PM - RTT News


Mylan To Present At J.P. Morgan Healthcare Conference; Webcast At 7:30 PM ET
1/13/2015 3:01:00 PM - RTT News


Generics Prices Spike: 2 Stock Choices - Analyst Blog
1/12/2015 2:46:00 PM - Investopedia


Generics Prices Spike: 2 Stock Choices - Analyst Blog
1/12/2015 2:46:00 PM - Zacks.com


Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
1/9/2015 4:39:00 PM - Zacks.com


Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
1/9/2015 4:39:00 AM - Investopedia


Mylan Ex-CEO and Glass Lewis Debate Proxy Adviser Power
1/8/2015 11:12:00 AM - TheStreet


Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog
1/7/2015 4:35:00 PM - Zacks.com


Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog
1/7/2015 4:35:00 AM - Investopedia


Mylan Announces U.S. Launch Of Generic Diovan Tablets
1/5/2015 1:46:00 PM - RTT News


2 Generic Drug Makers Worth A Look In 2015
12/31/2014 11:41:00 AM - Seeking Alpha


Health Care Sector Update for 12/31/2014: RDHL, SCMP, MYL
12/31/2014 8:39:50 AM - MT Newswires


Epirus Biopharma: A High Risk/High Reward Biosimilar Investment
12/31/2014 6:59:00 AM - Seeking Alpha


Mylan Selected As Supplier Of ARV Medications By South African Government
12/31/2014 6:18:00 AM - RTT News


Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog
12/22/2014 5:51:00 PM - Zacks.com


Hold On To Teva!
12/22/2014 3:09:00 PM - Seeking Alpha


Health Care Sector Update for 12/22/2014: CFRX, KERX, MYL
12/22/2014 8:47:10 AM - MT Newswires


Mylan Launches First Generic Version Of Vivelle-DOT - Quick Facts
12/22/2014 7:41:00 AM - RTT News